Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

BACKGROUND: Compared with older 5‐HT(3) receptor antagonists, palonosetron requires fewer drug administrations to prevent chemotherapy‐induced nausea and vomiting (CINV) following multiple‐day chemotherapy. We conducted a phase II multicenter study comparing palonosetron plus aprepitant to palonoset...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Di Renzo, Nicola, Melillo, Lorella, Porretto, Fernando, Dargenio, Michela, Pavone, Vincenzo, Pastore, Domenico, Mazza, Patrizio, Mannina, Donato, Merenda, Anxur, Cascavilla, Nicola, Greco, Giuseppina, Matera, Rosella, Bonizzoni, Erminio, Celio, Luigi, Musso, Maurizio
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943081/
https://ncbi.nlm.nih.gov/pubmed/31725196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2628
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky